These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28546543)

  • 1. Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity.
    Couto Alves A; Valcarcel B; Mäkinen VP; Morin-Papunen L; Sebert S; Kangas AJ; Soininen P; Das S; De Iorio M; Coin L; Ala-Korpela M; Järvelin MR; Franks S
    Int J Obes (Lond); 2017 Sep; 41(9):1331-1340. PubMed ID: 28546543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
    Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome.
    Chen L; Xu WM; Zhang D
    Fertil Steril; 2014 Oct; 102(4):1167-1174.e4. PubMed ID: 25064406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome.
    Falcetta P; Benelli E; Molinaro A; Di Cosmo C; Bagattini B; Del Ghianda S; Salvetti G; Fiore E; Pucci E; Fruzzetti F; Tonacchera M
    J Endocrinol Invest; 2021 Dec; 44(12):2725-2733. PubMed ID: 34089497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 10. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
    Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
    Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In women with PCOS, waist circumference is a better surrogate of glucose and lipid metabolism than disease status per se.
    Pazderska A; Kyaw Tun T; Phelan N; McGowan A; Sherlock M; Behan L; Boran G; Gibney J
    Clin Endocrinol (Oxf); 2018 Apr; 88(4):565-574. PubMed ID: 29285778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome.
    Zhang Z; Hong Y; Chen M; Tan N; Liu S; Nie X; Zhou W
    Metabolomics; 2020 Jan; 16(2):20. PubMed ID: 31980950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
    Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
    Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Tulberg A; Leung KL; Fisch SC; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2021 Jul; 116(1):232-242. PubMed ID: 33341231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome.
    Juan CC; Chen KH; Chen CW; Ho CH; Wang PH; Chen HS; Hwang JL; Lin YH; Seow KM
    Fertil Steril; 2021 Oct; 116(4):1139-1146. PubMed ID: 34119324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
    Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.